- Home
- HDL vs HQL Comparison
HDL vs HQL Comparison
Compare HDL & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HDL | HQL |
|---|---|---|
| Founded | 2016 | 1992 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Investment Managers |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 582.5M | 539.1M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | HDL | HQL |
|---|---|---|
| Price | $10.69 | $18.33 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $17.60 | N/A |
| AVG Volume (30 Days) | 1.8K | ★ 103.5K |
| Earning Date | 11-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | N/A | N/A |
| Revenue This Year | $9.19 | N/A |
| Revenue Next Year | $14.22 | N/A |
| P/E Ratio | $55.56 | ★ $23.23 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.74 | $15.66 |
| 52 Week High | $18.33 | $22.67 |
Technical Indicators
Market Signals| Indicator | HDL | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 44.13 | 49.86 |
| Support Level | $10.68 | $17.13 |
| Resistance Level | $14.04 | $19.00 |
| Average True Range (ATR) | 0.22 | 0.60 |
| MACD | -0.01 | 0.09 |
| Stochastic Oscillator | 43.89 | 56.47 |
Price Performance
Historical ComparisonAbout HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares
Super Hi International Holding Ltd is an investment holding company, and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan. Its mission is to become a world-wide integrated restaurant group, build the world's Chinese cuisine brand, and promote Chinese culinary heritage world-wide.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.